| Application no. and date | 12190525.1 (espacenet) (Federated) (European Patent Register), 20101111 | | Patent/reg. no. and date | DK/EP 2554183, 20180404 | | Publication date | 20130206 | | Priority no. and date | DE 102009052831, 20091113, DE 102010020902, 20100518 | | EP pub. no. and date |
EP 2554183 20130206 | | Effective date | | | Applicant/owner | Sanofi-Aventis Deutschland GmbH, Brüningstraße 50
65929 Frankfurt am Main, DE | | Applicant ref. no. | SAN DE2009-205-EPT2 | | Inventor | SCHOETTLE, Isabell, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
SIEFKE-HENZLER, Verena, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
HAUCK, Gerrit, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
HAGENDORF, Annika, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
MÜLLER, Werner, c/o Sanofi-Aventis Deutschland GmbH
65926Frankfurt am Main, DE,
TERTSCH, Katrin, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 38/26 (2006.01) , A61K 38/28 (2006.01) , A61K 47/10 (2017.01) , A61K 47/18 (2017.01) , A61K 9/00 (2006.01) , A61P 3/10 (2006.01) | | Title | Farmaceutisk præparat omfattende en GLP-1-agonist, et insulin og methionin | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
